Solventum Corp
Fermé
75.55 2.08
Résumé
Variation du prix de l'action
24h
Min
73.68
Max
75.86
Revenu | -50M 13M |
|---|---|
Ventes | 9M 2B |
P/E Moyenne du Secteur | 9.004 31.796 |
BPA | 1.48 |
Marge bénéficiaire | 0.648 |
Employés | 20,584 |
EBITDA | -276M 213M |
Recommandations | Achat |
|---|---|
Prévisions sur 12 Mois | +9.8% upside |
Prochains Résultats | 6 août 2026 |
|---|
Capitalisation Boursière | 1B 13B |
|---|---|
Ouverture précédente | 73.47 |
Clôture précédente | 75.55 |
Solventum Corp Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
À Propos Solventum Corp
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.